Eurofins Scientific SE (ERF.PA)
Company Info
Highlights
€10.12B
€2.09
27.15
0.59
€6.95B
€726.20M
€1.39B
€38.59 - €57.78
€58.73
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Eurofins Scientific SE (ERF.PA) returned 16.77% year-to-date (YTD) and 5.15% over the past 12 months. Over the past 10 years, ERF.PA returned 8.17% annually, underperforming the S&P 500 benchmark at 10.85%.
ERF.PA
16.77%
5.25%
22.62%
5.15%
-12.17%
-0.10%
8.17%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of ERF.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5.17% | -6.85% | 1.88% | 13.99% | 2.63% | 16.77% | |||||||
| 2024 | -4.88% | -1.53% | 6.95% | -2.51% | -3.89% | -15.91% | 19.14% | -5.84% | 10.19% | -20.60% | 3.56% | 5.39% | -15.45% |
| 2023 | -1.97% | 0.40% | -6.61% | 2.63% | -2.56% | -5.65% | 9.48% | -9.17% | -5.88% | -10.60% | 11.56% | 10.53% | -10.51% |
| 2022 | -18.41% | 1.99% | -0.70% | -1.32% | -2.14% | -13.52% | 2.62% | -9.10% | -11.55% | 5.99% | 2.53% | 0.96% | -37.53% |
| 2021 | 15.37% | -7.00% | 10.69% | 1.03% | 7.19% | 9.21% | 5.35% | 19.08% | -7.69% | -8.03% | 10.79% | -3.67% | 59.66% |
| 2020 | -1.66% | -6.42% | -0.84% | 11.97% | 20.36% | -8.09% | -1.22% | 21.71% | 0.57% | 1.24% | -0.47% | 0.84% | 38.87% |
| 2019 | 7.85% | 5.29% | -0.32% | 10.57% | -0.20% | -4.47% | -0.05% | 7.88% | 2.40% | 6.52% | 4.93% | 3.69% | 52.70% |
| 2018 | 3.43% | -11.70% | -7.46% | 4.38% | -1.88% | 8.96% | -2.06% | 4.24% | 0.53% | -8.71% | -14.20% | -14.88% | -35.46% |
| 2017 | 2.47% | -2.82% | 1.13% | 10.85% | 4.57% | 4.73% | -4.61% | 2.06% | 11.35% | 0.45% | -5.27% | -0.22% | 25.83% |
| 2016 | -5.97% | 8.41% | -1.75% | 0.53% | 7.55% | -3.84% | 0.55% | 8.33% | 11.27% | 2.36% | -0.23% | -1.93% | 26.41% |
| 2015 | 7.76% | 6.11% | 3.42% | 0.38% | 10.09% | -0.97% | 9.50% | -0.07% | -8.08% | 19.86% | 8.19% | -9.64% | 52.50% |
| 2014 | -3.92% | 12.18% | 2.57% | -7.94% | 12.50% | 0.35% | -0.73% | -3.05% | -5.16% | -1.63% | -3.20% | 8.63% | 8.49% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ERF.PA is 53, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Eurofins Scientific SE (ERF.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Eurofins Scientific SE provided a 1.93% dividend yield over the last twelve months, with an annual payout of €1.10 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | €1.10 | €0.50 | €1.00 | €1.00 | €0.68 | €0.00 | €0.29 | €0.24 | €0.20 | €0.15 | €0.13 | €0.12 |
Dividend yield | 1.93% | 1.01% | 1.70% | 1.49% | 0.62% | 0.00% | 0.58% | 0.74% | 0.39% | 0.36% | 0.41% | 0.57% |
Monthly Dividends
The table displays the monthly dividend distributions for Eurofins Scientific SE. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | €0.00 | €0.00 | €0.00 | €0.60 | €0.00 | €0.60 | |||||||
| 2024 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.50 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.50 |
| 2023 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.00 |
| 2022 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.00 |
| 2021 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.68 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.68 |
| 2020 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| 2019 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.29 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.29 |
| 2018 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.24 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.24 |
| 2017 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.20 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.20 |
| 2016 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.15 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.15 |
| 2015 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.13 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.13 |
| 2014 | €0.12 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.12 |
Dividend Yield & Payout
Dividend Yield
Eurofins Scientific SE has a dividend yield of 1.93%, which is quite average when compared to the overall market.
Payout Ratio
Eurofins Scientific SE has a payout ratio of 23.92%, which is below the market average. This means Eurofins Scientific SE returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Eurofins Scientific SE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Eurofins Scientific SE was 86.35%, occurring on Oct 10, 2002. Recovery took 842 trading sessions.
The current Eurofins Scientific SE drawdown is 52.51%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -86.35% | Nov 30, 2000 | 472 | Oct 10, 2002 | 842 | Jan 20, 2006 | 1314 |
| -68.1% | Nov 15, 2007 | 330 | Mar 3, 2009 | 793 | Mar 30, 2012 | 1123 |
| -67.37% | Jun 10, 1998 | 222 | Apr 28, 1999 | 160 | Dec 13, 1999 | 382 |
| -63.94% | Sep 22, 2021 | 707 | Jun 24, 2024 | — | — | — |
| -45.75% | Oct 31, 2017 | 326 | Feb 11, 2019 | 315 | May 8, 2020 | 641 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Eurofins Scientific SE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Eurofins Scientific SE, comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.
Valuation
The Valuation section provides an overview of how Eurofins Scientific SE is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ERF.PA, comparing it with other companies in the Diagnostics & Research industry. Currently, ERF.PA has a P/E ratio of 27.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ERF.PA compared to other companies in the Diagnostics & Research industry. ERF.PA currently has a PEG ratio of 0.6. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ERF.PA relative to other companies in the Diagnostics & Research industry. Currently, ERF.PA has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ERF.PA in comparison with other companies in the Diagnostics & Research industry. Currently, ERF.PA has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |